Triple reversal phenomenon in EGFR-mutant lung adenocarcinoma with prostate metastasis following hepatocellular carcinoma: a rare Case Report with diagnostic and therapeutic implications
BackgroundNon-small cell lung cancer harboring EGFR mutations is responsive to targeted therapies such as Osimertinib. Although metastasis from lung cancer to the prostate is exceedingly rare, we present a rare case of prostatic metastasis from lung adenocarcinoma in a patient with a history of hepa...
Saved in:
| Main Authors: | Jieyan Luo, Jie Zhou, Li Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1619466/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review
by: Jinhong Chen, et al.
Published: (2025-01-01) -
High-dose furmonertinib plus bevacizumab in EGFR-mutant non-small cell lung cancer with brain metastases after resistance to third-generation EGFR-TKIs: A retrospective study
by: Yin Pan, et al.
Published: (2025-11-01) -
Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT
by: Joon Yau Leong, et al.
Published: (2025-07-01) -
Analysis and characterization of chondroitin/dermatan sulfate composition of lung adenocarcinoma tissues with different types of genetic alterations in ALK, EGFR and KRAS oncogenes
by: Domonkos Pál, et al.
Published: (2025-06-01) -
De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis
by: Lili Shen, et al.
Published: (2025-08-01)